Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity

Natural killer (NK) cells are named based on their natural cytotoxic activity against a variety of target cells. However, the mechanisms by which sensitive targets activate killing have been difficult to study due to the lack of a prototypic NK cell triggering receptor. Pharmacologic evidence has im...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of experimental medicine Vol. 186; no. 12; pp. 1965 - 1974
Main Authors Brumbaugh, K M, Binstadt, B A, Billadeau, D D, Schoon, R A, Dick, C J, Ten, R M, Leibson, P J
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 15.12.1997
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Natural killer (NK) cells are named based on their natural cytotoxic activity against a variety of target cells. However, the mechanisms by which sensitive targets activate killing have been difficult to study due to the lack of a prototypic NK cell triggering receptor. Pharmacologic evidence has implicated protein tyrosine kinases (PTKs) in natural killing; however, Lck-deficient, Fyn-deficient, and ZAP-70-deficient mice do not exhibit defects in natural killing despite demonstrable defects in T cell function. This discrepancy implies the involvement of other tyrosine kinases. Here, using combined biochemical, pharmacologic, and genetic approaches, we demonstrate a central role for the PTK Syk in natural cytotoxicity. Biochemical analyses indicate that Syk is tyrosine phosphorylated after stimulation with a panel of NK-sensitive target cells. Pharmacologic exposure to piceatannol, a known Syk family kinase inhibitor, inhibits natural cytotoxicity. In addition, gene transfer of dominant-negative forms of Syk to NK cells inhibits natural cytotoxicity. Furthermore, sensitive targets that are rendered NK-resistant by major histocompatibility complex (MHC) class I transfection no longer activate Syk. These data suggest that Syk activation is an early and requisite signaling event in the development of natural cytotoxicity directed against a variety of cellular targets.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Address correspondence to Dr. Paul J. Leibson, Department of Immunology, Mayo Clinic and Foundation, Rochester, MN 55905. Phone: 507-284-4563; FAX: 507-284-1637; E-mail: leibson.paul@mayo.edu
ISSN:0022-1007
1540-9538
DOI:10.1084/jem.186.12.1965